Stockreport

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis

DURECT Corporation  (DRRX) 
Last durect corporation earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: durect.com/investors